Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Regulus Therapeutics (RGLS)

0.6596 0.004 (0.58%)

04-18 16:00

Open:

0.6566

Pre. Close:

0.6558

High:

0.675

Low:

0.6372

Volume:

332,032

Market Cap:

69M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.682 - 0.685

0.685 - 0.688

Low:

0.631 - 0.635

0.635 - 0.639

Close:

0.654 - 0.661

0.661 - 0.666

Technical analysis  (as of: 2018-04-18 4:43:55 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.92     One year: 1.04

Support:

Support1: 0.63    Support2: 0.52

Resistance:

Resistance1: 0.79    Resistance2: 0.89

Pivot:

0.67

Moving Averages:

MA(5): 0.65     MA(20): 0.71

MA(100): 1.01     MA(250): 1.11

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.09

%K %D:

%K(14,3): 13.42     %D(3): 9.10

RSI:

RSI(14): 32.71

52-Week:

High: 1.95  Low: 0.63  Change(%): -56.0

Average Vol(K):

3-Month: 56833  10-Days 35005

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RGLS has closed above bottom band by 40.7%. Bollinger Bands are 59.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to RGLS's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-17T16:10:00-04:00
Kathryn J. Collier Joins Regulus Board of Directors

2018-03-28T08:39:34-04:00
Premarket analyst action - healthcare

2018-03-20T16:15:00-04:00
Regulus to Present at the Needham Healthcare Conference

2018-03-08T12:38:01-05:00
Midday Gainers / Losers (3/8/2018)

2018-03-07T22:45:49-05:00
Regulus Therapeutics' (RGLS) CEO Jay Hagan on Q4 2017 Results - Earnings Call Transcript

2018-03-07T16:34:38-05:00
Regulus Therapeutics beats by $0.02, misses on revenue

2018-03-07T16:10:00-05:00
Regulus Reports Fourth Quarter and Year-end 2017 Financial Results and Pipeline Update

2018-03-05T19:01:00-05:00
Regulus to Present at the Cowen and Company 38th Annual Health Care Conference

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

103.96

Shares Float (M)

101.32

% Held by Insiders

2.50

% Held by Institutions

74.10

Shares Short (K)

1703

Shares Short Prior Month (K)

Stock Financials

EPS

-1.110

EPS Est. Current Year

-0.960

EPS Est. Next Year

-0.400

EPS Est. Next Quarter

-0.160

Forward EPS

1.#IO

Book Value (p.s.)

1.880

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-80.6

Return on Equity (ttm)

-157.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.519

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-0.59

P/E Growth Ratio

-0.02

P/BV

0.35

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.